Author(s): Rolfs, Prof. Arndt, MD, Giese, Anne Katrin, MD, Wanner, Christoph, MD, Weidemann, Frank, MD, Duning, Prof. Thomas, MD, Lenders, Malte, PhD, Hennermann, Prof. Julia B., MD, Kurschat, Christine Elisabeth, MD, Canaan-Kühl, Sima, MD, Sommer, Prof. Claudia, MD, Üçeyler, Prof. Nurcan, MD, Kampmann, Christopf, MD PhD, Karabul, Nesrin, MD, Stypmann, Prof. Jörg, MD, Krämer, Johannes, MD, Brand, Prof. Stefan-Martin, MD PhD, Brand, Prof. Eva, MD PhD
The aim of this study was to assess manifestations of and applied treatment concepts for females with Fabry disease according to the current European Guidelines. Read more!
The aim of the present study was to assess manifestations of and applied treatment concepts for females with Fabry disease (FD) according to the current European Fabry Guidelines. Between 10/2008 and 12/2014, data from the most recent visit of 261 adult female FD patients from six German Fabry centers were retrospectively analyzed. Clinical presentation and laboratory data, including plasma lyso-Gb3 levels were assessed.
Read publication (PDF)
